Also, the fact that all patients had information regarding main somatic driver mutations, greatly adds to the strength of this study, enabling us to demonstrate differential effects of TET2 rs154843 SNP on various molecular MPN subtypes. The gene discussed is TET2; the disease is myeloproliferative neoplasm.